Results 161 to 170 of about 784,460 (315)

Human Chorionic Gonadotropin as a Tumor Marker of Colorectal Cancer: A Case Report in a Non-pregnant Patient. [PDF]

Cureus
Castanheira D, Alves AR, Ferreira BO, Fernandes A, Duarte I.   +4 more
europepmc   +1 more source

Diagnostic value of cerebrospinal fluid cytology in comparison with tumor marker activity in central nervous system metastases secondary to breast cancer [PDF]

, 1993
Flemming W. Bach, Flemming W. Bach, Beth Bjerregaard, Thomas Horn, György Sölétormos, Flemming W. Bach, Flemming W. Bach   +6 more
openalex   +1 more source

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

Molecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

A composite immune-nutritional and tumor marker score predicts outcomes in LA-ESCC treated with neoadjuvant chemoimmunotherapy and surgery. [PDF]

Discov Oncol
Fan Y, Zhou J, Liu X, Ren Q, Lu S, Jin W.   +5 more
europepmc   +1 more source

Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer

Molecular Oncology, EarlyView.
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu, Puspa Das, Xing Zhang, Xiaodong Cheng   +3 more
wiley   +1 more source

When Carcinoembryonic Antigen Misleads: A Benign Cause of Tumor Marker Elevation. [PDF]

Cureus
Alhasan S, Alzafiri A, Tharwat H, Alhasan R, Alrashidi N.   +4 more
europepmc   +1 more source

Tumor endothelial marker 1 ( Tem1 ) functions in the growth and progression of abdominal tumors

, 2006
Akash Nanda, Baktiar Karim, Zhongsheng Peng, Guosheng Liu, Weiping Qiu, Christine Gan, Bert Vogelstein, Brad St. Croix, Kenneth W. Kinzler, David L. Huso   +9 more
openalex   +1 more source

Interferon beta drives therapy resistance in a patient‐derived model of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Interferon type 1 (IFN‐1) production and signaling is associated with the acquisition of therapy resistance, following chronic DNA damage, via Interferon‐related DNA damage resistance signature (IRDS) gene expression. An alternative, DNA damage‐independent role of sustained IFN‐1 mediated resistance was identified and characterized by the emergence of ...
Ashlyn Conant, Tise Suzuki, Kiera McGivney, V. S. S. Abhinav Ayyadevara, Sharon Asariah, Jay Deng, Ethan Nyein, Jacqueline Coats, Gary Yu, Yevgeniya J. Ioffe, Christian Hurtz, Juli J. Unternaehrer   +11 more
wiley   +1 more source

Tumor marker-guided precision BNCT for CA19-9-positive cancers: a new paradigm in molecularly targeted chemoradiation therapy. [PDF]

J Transl Med
Kanehira N, Teraishi F, Tajima T, Osone T, Gotoh K, Fujimoto T, Sakurai Y, Kondo N, Nagahisa N, Kamei K, Fujita T, Morihara A, Takaguchi Y, Kitamatsu M, Takarada T, Shigeyasu K, Suzuki M, Fujiwara T, Michiue H.   +18 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source